primary trigeminal neuralgia
Conditions
Interventions
Carbamazepine group (Group A):A. Carbamazepine group scheme:
Carbamazepine tablets, the initial dose is 0. 1g, 3 times/day, after meals. If the pain relief is not obvious, the dosage can be increased
,rTMS group (Group B):B.ritms Group:
The therapeutic parameters of rTMS are:
Stimulation frequency: 10Hz
Stimulation intensity: 80% MT
Total pulse count: 1200
Stimulation site: M1 area of motor c
Sponsors
Third Hospital of the Air Force Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria of primary trigeminal neuralgia; (2) Recurrence of surgical treatment; (3) All patients gave informed consent to this study.
Exclusion criteria
Exclusion criteria: (a) Patients with intracranial metal implantation and increased intracranial pressure; (b) Cardiac pacemaker installer; (c) Cochlear implants, wearers of in-ear hearing AIDS; (d) A history or family history of epilepsy; (e) Persons who have been treated for electric convulsions within the last 1 month; (f) Abnormal recent EEG examination; (g) Pregnant women, infants and young children and persons unable to express their feelings. Presence of metallic foreign bodies in the body; (h) Combined with other brain diseases; (i) Allergy to the investigational drug; (j) Behavioural cognitive impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual analogue scales;Pittsburgh Sleep Quality Index Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse Effects Rate;Recurrence; | — |
Countries
china
Contacts
Public Contactzhangyi
Third Hospital of the Air Force Medical University
Outcome results
None listed